Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Immunomedics revenue decreased from $2.2 million in 2018 to $295 thousand in 2019, a (86.3%) decrease.

Annual Revenue ($)

Immunomedics revenue was $295 k in FY, 2019 which is a (86.3%) year over year decrease from the previous period.

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019
Revenue$3.09 m$2.16 m$295 k
Q1, 2018Q2, 2018Q3, 2018Q2, 2020
Revenue$690.49 k$597.28 k$482.23 k$20.07 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Immunomedics revenue breakdown by business segment: 15.3% from License fee and other revenues, 69.6% from Product sales and 15.1% from Research and development

FY, 2018FY, 2017
License fee and other revenues$329.96 k$284.29 k
Product sales$1.5 m$2.44 m
Research and development$325.42 k$363.57 k

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu